Clinical Trial

The Application Value of Spectral CT in the Accurate Staging of Breast Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 18, 2025 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Spectral CT was used to prospectively collect medical images and clinical data related to breast cancer, evaluate the effect of image quality in the diagnosis of breast cancer, and evaluate the application value in the accurate staging of breast cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
Trial Details
NCT Number NCT06977412
Lead Sponsor Yunnan Cancer Hospital
Conditions Breast Adenocarcinoma
Enrollment 150 participants
Start Date 2025-06-01
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-18